Scientific Papers

Psychometric properties of the Clinical Assessment Interview for Negative Symptoms (CAINS) in patients with depression and its relationship to affective symptoms | Annals of General Psychiatry


  • Kirkpatrick B, Fenton WS, Carpenter WT Jr, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32:214–9. https://doi.org/10.1093/schbul/sbj053.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Galderisi S, Mucci A, Buchanan RW, Arango C. Negative symptoms of schizophrenia: new developments and unanswered research questions. Lancet Psychiatry. 2018;5:664–77. https://doi.org/10.1016/S2215-0366(18)30050-6.

    Article 
    PubMed 

    Google Scholar
     

  • Marder SR, Galderisi S. The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017;16:14–24. https://doi.org/10.1002/wps.20385.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Upthegrove R, Marwaha S, Birchwood M. Depression and Schizophrenia: Cause, Consequence, or Trans-diagnostic Issue? Schizophr Bull. 2017;43:240–4. https://doi.org/10.1093/schbul/sbw097.

    Article 
    PubMed 

    Google Scholar
     

  • Demyttenaere K, Anthonis E, Acsai K, Correll CU. Depressive symptoms and panss symptom dimensions in patients with predominant negative symptom schizophrenia: a network analysis. Front Psychiatry. 2022;13: 795866. https://doi.org/10.3389/fpsyt.2022.795866.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ahangari M, Bustamante D, Kirkpatrick R, Nguyen TH, Verrelli BC, Fanous A, et al. Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia. Br J Psychiatry. 2022. https://doi.org/10.1192/bjp.2022.179.

    Article 

    Google Scholar
     

  • Kirschner M, Schmidt A, Hodzic-Santor B, Burrer A, Manoliu A, Zeighami Y, et al. Orbitofrontal-striatal structural alterations linked to negative symptoms at different stages of the schizophrenia spectrum. Schizophr Bull. 2021;47:849–63. https://doi.org/10.1093/schbul/sbaa169.

    Article 
    PubMed 

    Google Scholar
     

  • Galderisi S, Mucci A, Dollfus S, Nordentoft M, Falkai P, Kaiser S, et al. EPA guidance on assessment of negative symptoms in schizophrenia. Eur Psychiatry. 2021;64: e23. https://doi.org/10.1192/j.eurpsy.2021.11.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Meiseberg J, Moritz S. Biases in diagnostic terminology: clinicians choose different symptom labels depending on whether the same case is framed as depression or schizophrenia. Schizophr Res. 2020;222:444–9. https://doi.org/10.1016/j.schres.2020.03.050.

    Article 
    PubMed 

    Google Scholar
     

  • Chaturvedi SK, Sarmukaddam S. Negative symptoms in depression. Indian J Psychiatry. 1985;27:139–44.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Galynker II, Cohen LJ, Cai J. Negative symptoms in patients with major depressive disorder: a preliminary report. Neuropsychiatry Neuropsychol Behav Neurol. 2000;13:171–6.

    CAS 
    PubMed 

    Google Scholar
     

  • Bottlender R, Sato T, Groll C, Jager M, Kunze I, Moller HJ. Negative symptoms in depressed and schizophrenic patients: how do they differ? J Clin Psychiatry. 2003;64:954–8. https://doi.org/10.4088/jcp.v64n0816.

    Article 
    PubMed 

    Google Scholar
     

  • Chuang JY, Murray GK, Metastasio A, Segarra N, Tait R, Spencer J, et al. Brain structural signatures of negative symptoms in depression and schizophrenia. Front Psychiatry. 2014;5:116. https://doi.org/10.3389/fpsyt.2014.00116.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Richter J, Holz L, Hesse K, Wildgruber D, Klingberg S. Measurement of negative and depressive symptoms: Discriminatory relevance of affect and expression. Eur Psychiatry. 2019;55:23–8. https://doi.org/10.1016/j.eurpsy.2018.09.008.

    Article 
    PubMed 

    Google Scholar
     

  • Krynicki CR, Upthegrove R, Deakin JFW, Barnes TRE. The relationship between negative symptoms and depression in schizophrenia: a systematic review. Acta Psychiatr Scand. 2018;137:380–90. https://doi.org/10.1111/acps.12873.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kim YK, Park SC. An alternative approach to future diagnostic standards for major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2021;105: 110133. https://doi.org/10.1016/j.pnpbp.2020.110133.

    Article 
    PubMed 

    Google Scholar
     

  • Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am J Psychiatry. 2013;170:165–72. https://doi.org/10.1176/appi.ajp.2012.12010109.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Haguiara B, Koga G, Diniz E, Fonseca L, Higuchi CH, Kagan S, et al. What is the best latent structure of negative symptoms in schizophrenia? A systematic review. Schizophr Bull Open. 2021;2:sgab013. https://doi.org/10.1093/schizbullopen/sgab013.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33 (quiz 4-57).

    PubMed 

    Google Scholar
     

  • Boden R, Bengtsson J, Thornblom E, Struckmann W, Persson J. Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression—a randomized controlled trial. J Affect Disord. 2021;290:308–15. https://doi.org/10.1016/j.jad.2021.04.053.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Persson J, Struckmann W, Gingnell M, Fallmar D, Boden R. Intermittent theta burst stimulation over the dorsomedial prefrontal cortex modulates resting-state connectivity in depressive patients: a sham-controlled study. Behav Brain Res. 2020;394: 112834. https://doi.org/10.1016/j.bbr.2020.112834.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Llerena K, Park SG, McCarthy JM, Couture SM, Bennett ME, Blanchard JJ. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms. Compr Psychiatry. 2013;54:568–74. https://doi.org/10.1016/j.comppsych.2012.12.001.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shafer A, Dazzi F, Ventura J. Factor structure of the Brief Psychiatric Rating Scale – Expanded (BPRS-E) in a large hospitalized sample. J Psychiatr Res. 2017;93:79–86. https://doi.org/10.1016/j.jpsychires.2017.05.011.

    Article 
    PubMed 

    Google Scholar
     

  • Guy W. ECDEU assessment manual for psychopharmacology publication. Washington: Department of health, education and welfare; 1976.


    Google Scholar
     

  • Ahmad I, Sandberg M, Brus O, Ekman CJ, Hammar Å, Landén M, et al. Validity of diagnoses, treatment dates, and rating scales in the Swedish national quality register for electroconvulsive therapy. Nord J Psychiatry. 2022;76:96–103. https://doi.org/10.1080/08039488.2021.1939416.

    Article 
    PubMed 

    Google Scholar
     

  • Svanborg P, Asberg M. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS). J Affect Disord. 2001;64:203–16. https://doi.org/10.1016/s0165-0327(00)00242-1.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Parker RD, Flint EP, Bosworth HB, Pieper CF, Steffens DC. A three-factor analytic model of the MADRS in geriatric depression. Int J Geriatr Psychiatry. 2003;18:73–7. https://doi.org/10.1002/gps.776.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Watanabe K, Fujimoto S, Marumoto T, Kitagawa T, Ishida K, Nakajima T, et al. Therapeutic potential of vortioxetine for anhedonia-like symptoms in depression: a post hoc analysis of data from a clinical trial conducted in Japan. Neuropsychiatr Dis Treat. 2022;18:363–73. https://doi.org/10.2147/NDT.S340281.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Diaz AP, Fernandes BS, Teixeira AL, Mwangi B, Hasan KM, Wu MJ, et al. White matter microstructure associated with anhedonia among individuals with bipolar disorders and high-risk for bipolar disorders. J Affect Disord. 2022;300:91–8. https://doi.org/10.1016/j.jad.2021.12.037.

    Article 
    PubMed 

    Google Scholar
     

  • Zheng W, Gu LM, Sun CH, Zhou YL, Wang CY, Lan XF, et al. Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression. J Affect Disord. 2022;300:109–13. https://doi.org/10.1016/j.jad.2021.12.105.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Fekadu A, Wooderson S, Donaldson C, Markopoulou K, Masterson B, Poon L, et al. A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. J Clin Psychiatry. 2009;70:177–84. https://doi.org/10.4088/jcp.08m04309.

    Article 
    PubMed 

    Google Scholar
     

  • The EuroQol Group. A new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.

    Article 

    Google Scholar
     

  • Teni FS, Burström K, Devlin N, Parkin D, Rolfson O. Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden. Health Qual Life Outcomes. 2023;21:34. https://doi.org/10.1186/s12955-023-02115-z.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Burström K, Johannesson M, Diderichsen F. Health-related quality of life by disease and socio-economic group in the general population in Sweden. Health Policy. 2001;55:51–69. https://doi.org/10.1016/S0168-8510(00)00111-1.

    Article 
    PubMed 

    Google Scholar
     

  • Johansson R, Carlbring P, Heedman A, Paxling B, Andersson G. Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life. PeerJ. 2013;1: e98. https://doi.org/10.7717/peerj.98.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl 3):89–95.

    Article 
    PubMed 

    Google Scholar
     

  • Hörberg N, Kouros I, Ekselius L, Ramklint M. The Swedish version of the Sheehan Disability Scale: a valid and brief measure of functioning. Eur J Person Centered Healthc. 2016;4:1–7. https://doi.org/10.5750/ejpch.v4i1.1075.

    Article 

    Google Scholar
     

  • Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995;56:423–32. https://doi.org/10.15288/jsa.1995.56.423.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Källmén H, Berman AH, Jayaram-Lindström N, Hammarberg A, Elgán TH. Psychometric properties of the AUDIT, AUDIT-C, CRAFFT and ASSIST-Y among Swedish adolescents. Eur Addict Res. 2019;25:68–77. https://doi.org/10.1159/000496741.

    Article 
    PubMed 

    Google Scholar
     

  • Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol. 1999;14:167–77.

    CAS 
    PubMed 

    Google Scholar
     

  • Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 2007;64:532–42. https://doi.org/10.1001/archpsyc.64.5.532.

    Article 
    PubMed 

    Google Scholar
     

  • Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36. https://doi.org/10.7326/0003-4819-155-8-201110180-00009.

    Article 
    PubMed 

    Google Scholar
     

  • Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155–63. https://doi.org/10.1016/j.jcm.2016.02.012.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cronbach LJ, Warrington WG. Time-limit tests: estimating their reliability and degree of speeding. Psychometrika. 1951;16:167–88. https://doi.org/10.1007/BF02289113.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bengtsson J, Boden R, Neider D, Cernvall M. A blinded validation of the Swedish version of the Clinical Assessment Interview for Negative Symptoms (CAINS). Nord J Psychiatry. 2022;76:44–51. https://doi.org/10.1080/08039488.2021.1933174.

    Article 
    PubMed 

    Google Scholar
     

  • Jung SI, Woo J, Kim YT, Kwak SG. Validation of the Korean-Version of the Clinical Assessment Interview for Negative Symptoms of Schizophrenia (CAINS). J Korean Med Sci. 2016;31:1114–20. https://doi.org/10.3346/jkms.2016.31.7.1114.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res. 1990;3:247–51.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Valiente-Gomez A, Mezquida G, Romaguera A, Vilardebo I, Andres H, Granados B, et al. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS). Schizophr Res. 2015;166:104–9. https://doi.org/10.1016/j.schres.2015.06.006.

    Article 
    PubMed 

    Google Scholar
     

  • Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–76.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Engel M, Fritzsche A, Lincoln TM. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS). Psychiatry Res. 2014. https://doi.org/10.1016/j.psychres.2014.07.070.

    Article 
    PubMed 

    Google Scholar
     

  • Emmerson LC, Ben-Zeev D, Granholm E, Tiffany M, Golshan S, Jeste DV. Prevalence and longitudinal stability of negative symptoms in healthy participants. Int J Geriatr Psychiatry. 2009;24:1438–44. https://doi.org/10.1002/gps.2284.

    Article 
    PubMed 

    Google Scholar
     

  • Chan RC, Shi C, Lui SS, Ho KK, Hung KS, Lam JW, et al. Validation of the Chinese version of the Clinical Assessment Interview for Negative Symptoms (CAINS): a preliminary report. Front Psychol. 2015;6:7. https://doi.org/10.3389/fpsyg.2015.00007.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Porcelli S, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, et al. Social dysfunction in mood disorders and schizophrenia: clinical modulators in four independent samples. Prog Neuropsychopharmacol Biol Psychiatry. 2020;99: 109835. https://doi.org/10.1016/j.pnpbp.2019.109835.

    Article 
    PubMed 

    Google Scholar
     

  • Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299–312. https://doi.org/10.1016/S0140-6736(18)31948-2.

    Article 
    PubMed 

    Google Scholar
     

  • Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl. 1989;155:49–58.

    Article 

    Google Scholar
     



  • Source link